Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

In lab tests, the fungus killed 90-100% of mosquitoes—even when placed in a large room with competing scents from humans and real flowers.

An epigenetic sensor uses a 21st amino acid to illuminate protein dynamics in real time to observe changes within cells.

The findings reveal that LNPs come in a surprising variety of configurations and the differences correlate with their delivery capabilities.

A newly discovered nuclear role for HSL reveals how imbalances in its location within fat cells may contribute to both ...

Researchers are studying development of human pre-implantation embryos in an effort to improve success of embryo growth and development.

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

Five years after launching Enveda with $55,000 of personal savings, Viswa Colluru, PhD, CEO, saw his initial investment in the AI-powered developer of plant-based treatments more than pay off recently ...

Survival rates from small trial suggest that adding pazopanib to standard treatment for Ewing sarcoma in children may extend lives without adding severe toxicity.

The Dog Aging Project analyzed blood samples from companion dogs to uncover ptmAAs as biological markers of aging.

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.